Hoe ziet het werkveld er over een kleine 10 jaar uit? In deze podcast gaan de tafelgenoten in gesprek over de toekomst van IBD-behandeling.

U kunt de podcast direct via de player hierboven afspelen. Wilt u de aflevering liever opslaan om later te beluisteren, dan kunt u deze hier downloaden.

Download podcast


1. Predicting SAE (leukopenia & pancreatitis) on azathioprine
Shah et al, 2018. Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicity. Drug Metab Pers Ther. 2018 Mar 28;33(1):57-60

2. Al-Judaibi et al, 2016. Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease. J Popul Ther Clin Pharmacol. 2016;23(1):e26-36
E-health developments (IBDcoach – Lancet) & IBDREAM

3. Anti-inflammatory diet
Molendijk et al, 2019. Towards a Food Pharmacy: Immunologic Modulation through Diet. Nutrients. 2019 May 31;11(6). pii: E1239

4.Role of dietary fibers in the production of butyrate & benefits of butyrate
Venegas et al, 2019. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front Immunol. 2019 Mar 11;10:277

5. Home calprotectin tests
Young-Ho, 2018. Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases. Intest Res. 2018 Oct; 16(4): 507–508


7. Microbiome & FMT in UC
Kellermayer, 2019. Fecal microbiota transplantation: great potential with many challenges. Transl Gastroenterol Hepatol. 2019 May 25;4:40

Meer referenties